4//SEC Filing
Osborne Aaron 4
Accession 0001209191-19-022603
CIK 0001501756other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:48 PM ET
Size
5.9 KB
Accession
0001209191-19-022603
Insider Transaction Report
Form 4
Osborne Aaron
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-04-01+450,000→ 450,000 totalExercise: $5.41Exp: 2029-03-31→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of April 1, 2019 (the "Vesting Commencement Date"), and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
Documents
Issuer
Adverum Biotechnologies, Inc.
CIK 0001501756
Entity typeother
Related Parties
1- filerCIK 0001772432
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:48 PM ET
- Size
- 5.9 KB